1. Home
  2. LOPE vs GPCR Comparison

LOPE vs GPCR Comparison

Compare LOPE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grand Canyon Education Inc.

LOPE

Grand Canyon Education Inc.

HOLD

Current Price

$160.97

Market Cap

4.1B

Sector

Real Estate

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$20.98

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOPE
GPCR
Founded
1949
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.8B
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
LOPE
GPCR
Price
$160.97
$20.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
16
Target Price
★ $194.00
$105.78
AVG Volume (30 Days)
266.6K
★ 1.2M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 4.57
N/A
Revenue
★ $511,257,000.00
N/A
Revenue This Year
$5.60
N/A
Revenue Next Year
$6.15
N/A
P/E Ratio
$35.32
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$134.27
$21.55
52 Week High
$223.04
$94.90

Technical Indicators

Market Signals
Indicator
LOPE
GPCR
Relative Strength Index (RSI) 66.75 13.66
Support Level $160.00 N/A
Resistance Level $175.09 $56.63
Average True Range (ATR) 3.83 1.58
MACD 0.68 -0.28
Stochastic Oscillator 88.16 2.01

Price Performance

Historical Comparison
LOPE
GPCR

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: